Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05902871Not ApplicableRecruiting

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

Role: lead

NCT03750201Not ApplicableCompleted

A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty

Role: lead

NCT05043831Not ApplicableWithdrawn

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial

Role: lead

NCT05271734Not ApplicableCompleted

Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Procedure

Role: lead

NCT04758598Not ApplicableCompleted

The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study

Role: lead

NCT01383525Not ApplicableCompleted

Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma

Role: lead

All 6 trials loaded